Sonic Healthcare Limited (SHL.AX)
ASX · AUD · Healthcare · Diagnostics & Research
A$19.05 (-0.21%) as of
Key statistics
- Market cap
- 9.42B
- P/E (TTM)
- 15.36
- Forward P/E
- 14.58
- EPS (TTM)
- 1.24
- Dividend yield
- 5.66%
- 52-week range
- 18.11 – 24.27
- Beta
- 0.57
- Revenue (TTM)
- 10.87B
- Profit margin
- 5.60%
- Analyst target
- A$22.12
- Volume
- 1.21M
About Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Sydney, NSW, Australia
- Employees
- 47,000
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.